S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)
S&P 500   4,513.04 (-1.18%)
DOW   34,022.04 (-1.34%)
QQQ   387.12 (-1.70%)
AAPL   164.77 (-0.32%)
MSFT   330.08 (-0.15%)
FB   310.60 (-4.27%)
GOOGL   2,821.03 (-0.60%)
AMZN   3,443.72 (-1.81%)
TSLA   1,095.00 (-4.35%)
NVDA   314.35 (-3.80%)
BABA   122.49 (-3.95%)
NIO   38.31 (-2.10%)
CGC   9.94 (-7.19%)
AMD   149.11 (-5.85%)
GE   93.00 (-2.09%)
MU   85.15 (+1.37%)
T   22.23 (-2.63%)
F   19.58 (+2.03%)
DIS   142.15 (-1.90%)
PFE   54.68 (+1.77%)
AMC   28.57 (-15.82%)
ACB   6.01 (-6.39%)
BA   188.19 (-4.88%)

Biogen SEC Filings & 10K Form

$229.50
-6.24 (-2.65%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$228.88
$239.58
50-Day Range
$229.50
$293.20
52-Week Range
$228.68
$468.55
Volume
1.56 million shs
Average Volume
1.38 million shs
Market Capitalization
$33.71 billion
P/E Ratio
22.46
Dividend Yield
N/A
Beta
0.42

Biogen (NASDAQ:BIIB) SEC Filings

DateFilerForm TypeView
09/03/2021
3:08 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2021
6:08 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2021
4:30 PM
Biogen (Issuer)
Mulligan Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
4:29 PM
Biogen (Issuer)
LEAMING NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
4:28 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
4:27 PM
Biogen (Issuer)
PAPADOPOULOS STELIOS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
4:27 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
4:26 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
4:25 PM
Biogen (Issuer)
JONES WILLIAM D /CA/ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
3:34 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
5:04 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/29/2021
5:03 PM
Biogen (Issuer)
JONES WILLIAM D /CA/ (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/09/2021
6:05 PM
Biogen (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:04 PM
Biogen (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:18 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2021
6:02 PM
Biogen (Issuer)
Posner Brian S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
10:44 AM
Biogen (Subject)
McRitchie James (Filed by)
Form PX14A6G
04/23/2021
3:16 PM
Biogen (Filer)
Form DEFA14A
04/22/2021
3:14 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2021
6:08 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2021
3:41 PM
Biogen (Filer)
Form PRE 14A
04/09/2021
3:35 PM
Biogen (Filer)
Form DEFA14A
04/09/2021
3:33 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2021
3:21 PM
Biogen (Issuer)
Vounatsos Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:19 PM
Biogen (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:17 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:14 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:11 PM
Biogen (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:09 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:06 PM
Biogen (Issuer)
Galdes Alphonse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:03 PM
Biogen (Issuer)
Vounatsos Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
4:01 PM
Biogen (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:56 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:54 PM
Biogen (Issuer)
Galdes Alphonse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:52 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
3:31 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:15 PM
Biogen (Issuer)
Posner Brian S (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/09/2021
3:14 PM
Biogen (Issuer)
PANGIA ROBERT W (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/04/2021
8:10 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
6:04 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2021
3:47 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
3:45 PM
Biogen (Issuer)
Galdes Alphonse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
3:44 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
3:43 PM
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2021
3:41 PM
Biogen (Issuer)
Vounatsos Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:30 PM
Biogen (Reporting)
Biogen MA Inc. (Reporting)
Sage Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2021
3:19 PM
Biogen (Filed by)
Sage Therapeutics, Inc. (Subject)
Form SC 13G
12/09/2020
4:00 PM
Biogen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
12/07/2020
8:08 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
4:41 PM
Biogen (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2020
3:57 PM
Biogen (Issuer)
Vounatsos Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
8:39 PM
Biogen (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2020
4:16 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/21/2020
6:21 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
3:30 PM
Biogen (Reporting)
Biogen MA Inc. (Reporting)
Denali Therapeutics Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2020
3:11 PM
Biogen (Filed by)
Denali Therapeutics Inc. (Subject)
Form SC 13G
09/21/2020
4:15 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
4:17 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
3:21 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/22/2020
3:37 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2020
6:13 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2020
3:42 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
10:49 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2020
4:24 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:23 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:21 PM
Biogen (Issuer)
Posner Brian S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:20 PM
Biogen (Issuer)
PAPADOPOULOS STELIOS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:19 PM
Biogen (Issuer)
PANGIA ROBERT W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:17 PM
Biogen (Issuer)
Mulligan Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:16 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:15 PM
Biogen (Issuer)
LEAMING NANCY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:14 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:13 PM
Biogen (Issuer)
DORSA CAROLINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
3:21 PM
Biogen (Filer)
Form 424B2
04/27/2020
7:29 AM
Biogen (Filer)
Form 424B2
04/24/2020
7:28 AM
Biogen (Filer)
Form S-3ASR
04/22/2020
3:50 PM
Biogen (Reporting)
Biogen MA Inc. (Reporting)
SANGAMO THERAPEUTICS, INC (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2020
6:12 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2020
3:23 PM
Biogen (Filer)
Form DEFA14A
04/20/2020
3:21 PM
Biogen (Filer)
Form DEF 14A
04/17/2020
3:13 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G
03/12/2020
5:56 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:20 PM
Biogen (Issuer)
Vounatsos Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:17 PM
Biogen (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:13 PM
Biogen (Issuer)
Galdes Alphonse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:09 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:37 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:36 PM
Biogen (Issuer)
Karp Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:34 PM
Biogen (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:32 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:30 PM
Biogen (Issuer)
Galdes Alphonse (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:27 PM
Biogen (Issuer)
CAPELLO JEFFREY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:25 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:19 PM
Biogen (Issuer)
Vounatsos Michel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
5:16 PM
Biogen (Issuer)
Sandrock Alfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
1:40 PM
Biogen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
02/12/2020
10:01 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2020
3:58 PM
Biogen (Filed by)
IONIS PHARMACEUTICALS INC (Subject)
Form SC 13G/A
02/11/2020
3:56 PM
APPLIED GENETIC TECHNOLOGIES CORP (Subject)
Biogen (Filed by)
Form SC 13G/A
02/10/2020
5:33 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
This page was last updated on 12/1/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.